Vimarsana
Biggest News Aggregation in the World

Cornelia Eckert News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cornelia Eckert. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cornelia Eckert Today - Breaking & Trending Today

Moncrieff album of photographs of China | Items | National Library of New Zealand - Vimarsana News

Moncrieff album of photographs of China | Items | National Library of New Zealand

Album of photographs compiled by Agnes Meikle Moncrieff during her first term working for the YWCA in China, 1930-1934. Includes photographs of lo...

New personalized test to detect leukemia relapse sooner and avoid false negative results - Vimarsana News

New personalized test to detect leukemia relapse sooner and avoid false negative results

Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia (ALL), the most common cancer in children, to inform more effective treatment strategies and detect disease recurrence.

Chemotherapy drugs can induce mutations that lead to relapse in pediatric ALL patients - Vimarsana News

Chemotherapy drugs can induce mutations that lead to relapse in pediatric ALL patients

Chemotherapy drugs can induce mutations that lead to relapse in pediatric ALL patients Chemotherapy has helped make acute lymphoblastic leukemia (ALL) one of the most survivable childhood cancers. Now, researchers working in the U.S., Germany and China have shown how chemotherapy drugs called thiopurines can lead to mutations that set patients up for relapse. The work appears today in the journal Nature Cancer. The research provides the first direct genomic and experimental evidence in pediatric cancer that drug-resistant mutations can be induced by chemotherapy and are not always present at...

Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent - Vimarsana News

Mountain Valley MD Proceeding With Pre-Clinical Cancer Trials, Files Related Cancer Patent

Share this article Share this article TORONTO, May 3, 2021 /PRNewswire/ -  Mountain Valley MD Holdings Inc. (the " Company" or " MVMD") (CSE: MVMD) (FRA: 20MP) (OTCQB: MVMDF) is pleased to announce that the Company has filed a novel cancer adjuvant patent and is proceeding with pre-clinical trials with third-party cancer Contract Research Organizations (CROs) in triple-negative breast cancer, metastatic melanoma, and lung carcinoma. Summary MVMD files cancer patent for direct intratumoral injection, intravenously, infusions or instillations as adjuvants for broad chemotherapeutic to immunot...